Innovation and Partnership
Ceresensa is a technology-driven company that has been providing MRI resonators to research institutes, hospitals and drug discovery companies for many years. In addition to supplying RF resonator products to OEMs, Ceresensa provides a host of integrated contract research and development. The founders of Ceresensa were part of the innovative MR technology that began at Robarts Research Institute. The founders then sought to take the innovations towards commercialisation and acquired their own development and manufacturing facilities. Ceresensa is in continued collaboration with several research institutes, and most recently with Lawson Health Research Institute, National Institutes of Health (NIH), Massachusetts General Hospital (MGH), Robarts Research Institute, and Washington University. Partnership agreements with local and international imaging research facilities have given our scientists access to several research projects and clinical imaging products. The innovation powering Ceresensa’s multi-channel parallel imaging technology was developed to address the under-served clinical market for pediatric MRI solutions. Our unique PET/MRI and pediatric solutions are based on multi-channel conformal arrays, a proprietary patient positioning system to enhance workflow and the principles of patient-centred care. The Ceresensa team is proud to be at the forefront of MRI technologies and humbled to be part of improving the patient experience.